BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
KPT-127 is toxic to hematological cancer cells
Jan. 4, 2011
Sorafenib monotherapy ineffective in patients with advanced melanoma
Jan. 4, 2011
MK-2461 is active in model of multiple myeloma
Jan. 3, 2011
Novartis researchers claim novel PI3K and mTOR inhibitors
Jan. 3, 2011
Vascular Biogenics begins phase II trials of VB-111 in glioblastoma and thyroid cancer
Jan. 3, 2011
Tekmira Pharma begins phase I trial of TKM-080301 in solid tumors
Jan. 3, 2011
Selective SYK inhibitors P505-15 and P459-72 show anticancer potential
Jan. 3, 2011
Immatics Biotech begins phase III IMA-901 trial in renal cell carcinoma
Dec. 31, 2010
Medimmune begins phase Ib/II trial of MEDI-575 in NSCLC
Dec. 31, 2010
BioCancell Therapeutics completes preclinical studies of BC-821 for glioblastoma
Dec. 31, 2010
Previous
1
2
…
2513
2514
2515
2516
2517
2518
2519
2520
2521
…
4064
4065
Next